This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. Likewise, as of January 2021 hospitals must share prices online and provide plain-language descriptions of available services. That means providing more patient-friendly terminology is more than just a compliance checkbox.
The Inflation Reduction Act’s health insurance subsidies and drug pricing reforms will improve health care affordability for Americans but won’t do a damn thing for our overall healthcare costs, which will keep rising. A staggering 85% of healthcare costs in the U.S. Finally, there are healthcare administrative costs.
But increased competition is on the horizon. Competition starts to heat up. In a case filed in California in 2021, Molina Healthcare claimed Jazz Pharmaceuticals engaged in a “comprehensive anticompetitive scheme to suppress generic competition for Xyrem,” abused the REMS program, and “engaged in sham patent litigation.”.
digital health sector plummeted to $15 billion from more than $29 billion in 2021, according to Rock Health. billion in 2021. Trial access equity and inclusivity are important considerations for sponsors given the results of a 2021 analysis of U.S. Venture capital and other startup investment in the U.S. digital health at $17.7
Have you found that your 2021 strategies for engaging with your customers aren’t working as expected? In 2020 most pharmaceutical companies had to shift strategies to reach their customers via multi-channel, digital platforms, with hope that by 2021, everything would be back to normal. But the reality is, 2021 is far from that.
Oh no, 2021 has started and our plan is already outdated! In 2020 most pharmaceutical companies continued their strategic planning as if by 2021 everything would be back to normal. But the reality is, 2021 is far from that. We are changing our habits and your healthcare stakeholders aren’t any different. Sounds familiar?
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The first in class launches barely have time to establish before they face competition, and then the competition keeps on coming.
Sixty percent of employees in a recent survey reported experiencing healthcare cost increases that outpaced inflation in the past three years, and 63 percent expect that trend to continue, signaling potential cost challenges in the future. Right now, annual raises are being neutralized by increasing healthcare insurance premiums.
As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate oncology experts sifted through the more than 2,800 abstracts that were accepted for presentation at the ESMO 2021 Virtual Conference and selected their top picks. Context: In August 2021, Merck & Co.
And the findings are clear: Without a positive, up-to-date, and lively online presence, healthcare practices are falling behind and losing patients to the competition. Tune in to discover: How the travel industry revolutionized consumer insights and data collection and the path for healthcare to follow suit.
In the dynamic world of healthcare marketing, understanding your audience and optimizing your strategies are key to staying ahead of the competition. Practices can use healthcare data analytics to gain insights that can transform their marketing efforts in the digital age.
33:04 – Jaclene Corstorphine (Guest) You know, this question is it’s always hard for me, right, because I just do what I do, sure, and I think the one thing I would say is like I approach my approach to sales is really from a competitive nature. You know, I approach it like a competitive athlete. But I think beyond that.
Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. For less wealthy nations, competition isn’t even a possibility. Pfizer’s Paxlovid currently costs about $530 for a five-day course of the treatment. costs about $700.
More companies are making high-quality healthcare easier to access and more affordable by embracing data and technology. While healthcare has historically been among the slowest to accept new technologies, the pandemic has sped adoption. What is personalized healthcare, and how can you incorporate it into your marketing strategy?
Healthcare is a rapidly changing industry, and if you want to stay ahead of the curve, you’ll need to adopt some cutting-edge marketing strategies. As 2023 approaches, there are several strategies you can adopt to improve your healthcare marketing efforts and grow your practice. 6 Medical Marketing Strategies to Adopt in 2023.
Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.
In 2021 pharma provided a staggering $204 billion in price concessions for brand-name medicines to PBMs. Those health insurers, in turn, use the discounts to offer more competitive premiums in a bid to attract enrollees. Pharma companies have very little control over patients’ prices for their Rxs.
Marketing the importance of preventive healthcare services is challenging, costly, and often conflicts with consumer behavior. Influencing Consumer Behavior Through Digital Marketing Unfortunately, our healthcare system was built upon a fee-for-service model.
The 2021 NextGen Pharma Content , taking place on March 23-24 , will bring together content creators, marketers, and communications/PR practitioners to learn how to build trust and earn loyalty with customers to achieve a positive emotional connection with your brand. REGISTER TODAY!
In her opening statement, Izzy Gladstone, Reuters’ Head of Marketing, Pharma & Healthcare, challenged attendees to not return to our old ways of working. “To Pharma USA 2021 was committed to instilling in attendees what it will take to deliver true impact to patients, and to healthcare professionals who treat them.
healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.
In this episode of the Healthcare Leadership Podcast , host Jennifer Thompson engages in a dynamic discussion with Matthew Davis, Director of Channel Partnerships at Press Ganey. Together, they explore the latest 2021 Consumer Experience Trends in Healthcare report insights.
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
Many industries have undergone a rapid revolution during 2020, especially healthcare. As a medical sales professional looking ahead to 2021, now more than ever it is imperative to evaluate your strategy for the new year. Here are 21 tips to grow your medical sales business in 2021: 21 – Understand Pain Points.
This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA).
Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. .
Healthcare price transparency continues to grow, with health insurers required to release cost-sharing estimates beginning in 2022. What’s new for healthcare price transparency in 2021 ? The American healthcare system is ushering in a new era of health cost transparency. Why is price transparency important in healthcare?
Face-to-face interactions with healthcare providers or HCPs are declining. Leverage intelligence for immediate insight into competitive data that helps sales teams create stronger targeting strategies and personalized, highly contextual customer experiences. Trend 2: Evolved commercial strategies and models. Does such a system exist?
As healthcare practices strive to navigate the complexities of patient needs and preferences, the importance of fostering robust patient engagement strategies cannot be overstated. The Importance of Patient Engagement Personalization for patients is a key driver of improved healthcare outcomes.
Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be folded into the Clarivate portfolio of offerings for Life Sciences & Healthcare. Today, the Dialog Solutions brand has been integrated into Clarivate.
Amazon has accelerated its expansion into the healthcare sector with an all-cash deal to acquire One Medical, a US group that provides virtual and in-person primary care services using a subscription fee model. “We look forward to innovating and expanding access to quality healthcare services, together.”
billion in 2021, with a compounded annual growth rate (CAGR) of 3.1% What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. from 2022 to 2030.
Increasing competition for talent, as well as the uncertainty of remote versus in-person workspaces, impacts new hire engagement. According to Gallup’s monthly employment trends, the percentage of employees working from home full-time (25%) and some of the time (20%) remained steady between July and September 2021. EcoVadis.com.
ON 11 JANUARY 2022, Regulation (EU) 2021/2282 on health technology assessment (HTA) came into force. border healthcare, specifically by repealing Article 15, which originally laid down the modalities and principles for co-operation between Member States in assessing new health technologies. governmental healthcare organisations.
By leveraging data analytics to optimize and expand telemedicine capabilities, payers can effectively address the critical challenge of extending quality healthcare to underserved areas while managing costs. Long wait times can be frustrating for patients, but telemedicine can facilitate quick and easy access to healthcare.
The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. The second protection from surprise bills is for non-emergent settings when a patient receives care from an out-of-network healthcare provider while at an in-network facility.
In some ways, it is not difficult to understand why: healthcare faced unprecedented challenge from the COVID-19 pandemic and responded in an extraordinary way. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.
Healthcare prices in the U.S. Complying with the regulations won’t be enough for healthcare delivery organizations that want to thrive in this new, more transparent environment. While price transparency does present new, interesting challenges to healthcare delivery organizations, it also opens the door for new growth opportunities.
Vazkepa is a highly purified omega-3 fatty acid formulation that was approved for this indication by the Medicines and Healthcare products Regulatory Agency (MHRA) last year. In the REDUCE-IT study, which enrolled 8,179 statin-treated adult patients with moderately elevated triglyceride levels who were followed for a median duration of 4.9
The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. previously seen when Biocon and Viatris launched the interchangeable insulin biosimilar SEMGLEE, a biosimilar of Sanofi’s blockbuster long-acting insulin Lantus, in 2021 for a 65% discount over its equivalent.
The latest market study report from the Competition Bureau has provided recommendations to health care providers (HCPs) on how to improve the ways they work within Canada’s public health system. The new report states that digital health care is not being used to its full potential in Canada.
Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. billion in 2021 to $9.23 I believe huge opportunities await organisations that properly leverage their data.”.
Over the past year, the healthcare industry has widely embraced the use of telemedicine and digital health platforms largely as a response to the COVID-19 Public Health Emergency. The healthcare sector is the most vulnerable to cyberattacks and data breaches, accounting for nearly half of all data breaches.
What can Healthcare and Life Sciences businesses and investors anticipate for the healthcare industry in 2022? We asked our team five direct questions about innovations in healthcare, life sciences, and digital health in the coming year: What healthcare trends or opportunities are you most excited about?
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content